Compare INNV & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INNV | BLFS |
|---|---|---|
| Founded | 2007 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2021 | 2013 |
| Metric | INNV | BLFS |
|---|---|---|
| Price | $9.10 | $25.94 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $32.00 |
| AVG Volume (30 Days) | 293.1K | ★ 734.8K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $853,699,000.00 | $96,214,000.00 |
| Revenue This Year | $12.85 | $19.73 |
| Revenue Next Year | $8.88 | $17.82 |
| P/E Ratio | ★ N/A | $1,276.50 |
| Revenue Growth | 11.76 | ★ 16.97 |
| 52 Week Low | $3.13 | $17.86 |
| 52 Week High | $10.69 | $29.57 |
| Indicator | INNV | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 72.63 | 55.48 |
| Support Level | $7.25 | $23.60 |
| Resistance Level | $10.69 | $26.59 |
| Average True Range (ATR) | 0.44 | 1.41 |
| MACD | 0.21 | -0.24 |
| Stochastic Oscillator | 91.22 | 41.06 |
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.